Nuzenio

Vanguard Vistagen

Vanguard Vistagen news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Vistagen’s Fasedienol Phase 2 Data Due August 2026 for Social Anxiety - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:39:00 GMTVanguard Portfolio Management (VGNT) discloses 4.27M Versigent PLC shares in 6.01% stake - Stock TitanStock Titan · Fri, 31 Jul 2026 15:41:03 GMTVanguard Portfolio Management (G) discloses 10.4M-share Genpact Ltd position - Stock TitanStock Titan · Fri, 31 Jul 2026 15:20:16 GMTVanguard Capital Management (IMKTA) discloses 5.07% Ingles Markets ownership in 13G - Stock TitanStock Titan · Fri, 31 Jul 2026 14:20:12 GMT

Timeline

Fri, 07 Aug 2026 06:39:00 GMTVistagen’s Fasedienol Phase 2 Data Due August 2026 for Social Anxiety - The Clinical Trial Vanguard
Fri, 31 Jul 2026 15:41:03 GMTVanguard Portfolio Management (VGNT) discloses 4.27M Versigent PLC shares in 6.01% stake - Stock Titan
Fri, 31 Jul 2026 15:20:16 GMTVanguard Portfolio Management (G) discloses 10.4M-share Genpact Ltd position - Stock Titan
Fri, 31 Jul 2026 14:20:12 GMTVanguard Capital Management (IMKTA) discloses 5.07% Ingles Markets ownership in 13G - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Vanguard Vistagen.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.